Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery
Morteza Rabiei, Soheila Kashanian, Seyedeh Sabereh Samavati, Hossein Derakhshankhah, Shahriar Jamasb, Steven J. P. McInnes
Abstract
the pulmonary route is developing colloidal systems with the optimal physicochemical parameters for inhalation. The physiochemical properties of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been investigated as a template for the synthesis of NPs to assist in the formulation of virus-like particles (VLPs) for pharmaceutical delivery, vaccine production and diagnosis assays.
Topics & Concepts
AerosolizationBiopharmaceuticalDrug deliveryDrugMedicineMicrospherePharmacologyCoronavirus disease 2019 (COVID-19)NanotechnologyInhalationMaterials sciencePathologyBiologyDiseaseInfectious disease (medical specialty)AnesthesiaBiotechnologyEngineeringChemical engineeringInhalation and Respiratory Drug DeliveryScientific and Engineering Research TopicsCOVID-19 diagnosis using AI